Spelling suggestions: "subject:"hypoxia inducible factor 1α"" "subject:"ypoxia inducible factor 1α""
1 |
The anti-tumor efficacy of 2-deoxyglucose and D-allose are enhanced with p38 inhibition in pancreatic and ovarian cell linesMalm, S. W., Hanke, N. T., Gill, A., Carbajal, L., Baker, A. F. January 2015 (has links)
PURPOSE: The anti-tumor activity of glucose analogs 2-deoxy-glucose (2-DG) and D-allose was investigated alone or in combination with p38 mitogen-activated protein kinase (MAPK) inhibitor SB202190 or platinum analogs as a strategy to pharmacologically target glycolytic tumor phenotypes. METHODS: Hypoxia inducible factor-1 alpha (HIF-1alpha) protein accumulation in pancreatic cell lines treated with SB202190 alone and in combination with glucose analogs was analyzed by Western blot. HIF-1alpha transcriptional activity was measured in MIA PaCa-2 cells stably transfected with a hypoxia response element luciferase reporter following treatment with glucose analogs alone, and in combination with SB202190. Induction of cleaved poly(ADP-ribose) polymerase (PARP) was measured by Western blot in the MIA PaCa-2 cells. In vitro anti-proliferative activity of 2-DG and D-allose alone, or in combination with oxaliplatin (pancreatic cell lines), cisplatin (ovarian cell lines), or with SB202190 were investigated using the MTT assay. RESULTS: SB202190 decreased HIF-1alpha protein accumulation and transcriptional activity. 2-DG demonstrated greater anti-proliferative activity than D-allose. Pre-treatment with SB202190 enhanced activity of both 2-DG and D-allose in MIA PaCa-2, BxPC-3, ASPC-1, and SK-OV-3 cells. The combination of D-allose and platinum agents was additive to moderately synergistic in all but the OVCAR-3 and HEY cells. SB202190 pre-treatment further enhanced activity of D-allose and 2-DG with platinum agents in most cell lines investigated. CONCLUSIONS: SB202190 induced sensitization of tumor cells to 2-DG and D-allose may be partially mediated by inhibition of HIF-1alpha activity. Combining glucose analogs and p38 MAPK inhibitors with chemotherapy may be an effective approach to target glycolytic tumor phenotypes.
|
2 |
Fish health, condition and biomarkers : a mechanistic and environmental perspective on copper pollution / Daléne van HeerdenVan Heerden, Daléne January 2005 (has links)
Thesis (Ph.D. (Zoology))--North-West University, Potchefstroom Campus, 2005.
|
3 |
Fish health, condition and biomarkers : a mechanistic and environmental perspective on copper pollution / Daléne van HeerdenVan Heerden, Daléne January 2005 (has links)
Thesis (Ph.D. (Zoology))--North-West University, Potchefstroom Campus, 2005
|
4 |
Fish health, condition and biomarkers : a mechanistic and environmental perspective on copper pollution / Daléne van HeerdenVan Heerden, Daléne January 2005 (has links)
Thesis (Ph.D. (Zoology))--North-West University, Potchefstroom Campus, 2005
|
5 |
Hiperamonemia ativa HIF-1α pela via NF-kB : um possível mecanismo de sarcopenia em cirrose / Hyperammonemia activates HIF-1α via a NF-kB pathway : a possible mechanism for sarcopenia in cirrhosisSilva, Rafaella Nascimento e 15 September 2016 (has links)
Submitted by Ronildo Prado (ronisp@ufscar.br) on 2017-08-22T17:21:37Z
No. of bitstreams: 1
TeseRNS.pdf: 3515617 bytes, checksum: 251005e22df508ed87d98457bd4a5d3d (MD5) / Approved for entry into archive by Ronildo Prado (ronisp@ufscar.br) on 2017-08-22T17:21:47Z (GMT) No. of bitstreams: 1
TeseRNS.pdf: 3515617 bytes, checksum: 251005e22df508ed87d98457bd4a5d3d (MD5) / Approved for entry into archive by Ronildo Prado (ronisp@ufscar.br) on 2017-08-22T17:21:54Z (GMT) No. of bitstreams: 1
TeseRNS.pdf: 3515617 bytes, checksum: 251005e22df508ed87d98457bd4a5d3d (MD5) / Made available in DSpace on 2017-08-22T17:22:00Z (GMT). No. of bitstreams: 1
TeseRNS.pdf: 3515617 bytes, checksum: 251005e22df508ed87d98457bd4a5d3d (MD5)
Previous issue date: 2016-09-15 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) / Hyperammonemia impairs skeletal muscle protein synthesis and induces autophagy
by upregulating myostatin via nuclear factor-kappaB (NF-kB). Skeletal muscle
ammonia metabolism occurs via synthesis of glutamate and glutamine via critical TCA
intermediate α-KG, that regulates increase expression of hypoxia inducible factor 1α
(HIF-1α). Furthermore, there is a interaction between HIF-1α and NF-kB. Objective:
This study evaluated the effects of hyperammonemia in NF-kB and HIF-1α cross-talking.
Methods: To examine the effects of ammonium acetate intervention under HIF-1α
signaling through NF-kB pathway it has generated a stable knockdown cell line for NFkB
and the subunits α and β of the I kappa B kinase (IKK) complex (IKKα and IKKβ)
evaluating the HIF-1α and myostatin activities. Results: The protein expression of HIF-
1α was significantly higher in C2C12 murine myotubes under ammonium acetate intervention
compared to control. Once the deletion of NF-kB, IKKα and IKKβ occurs, the
HIF-1α is not expressed, suggesting a cross-talking between them. The protein expression
of myostatin was significantly higher in C2C12 IKKα deletion under ammonium
acetate intervention compared to C2C12 random suggesting that myostatin is not IKKα
dependent. Conclusion: We conclude that hyperammonemia is a normoxemic activator
of HIF-1α through NF-kB pathway that results in sarcopenia via up-regulation of myostatin
expression. / Um dos grandes mediadores de sarcopenia em cirrose é a hiperamonemia.
Esta anormalidade metabólica é frequente em doenças hepáticas promovendo conversão
danificada de amônia em uréia prejudicando a síntese protéica e induzindo autofagia do
músculo esquelético pela up-regulação de miostatina via fator nuclear kappa B (NFkB).
O metabolismo de amônia no músculo esquelético ocorre via síntese de glutamato
e glutamina através do intermediário metabólico α-cetoglutarato do ciclo de Krebs, que
regula o Fator Induzido por Hipóxia (HIF-1α). Além disso, existe um interação entre os
dois fatores de transcrição HIF-1α and NF-kB. Objetivo: Este estudo avalia os efeitos
da hiperamonemia no cross-talking entre NF-kB and HIF-1α. Métodos: Para examinar
os efeitos do aumento da concentração de amônia na expressão de HIF-1α através da via
NF-kB foi realizado um knockdown estável de NF-kB, e as subunidades IKKα e IKKβ
do complexo I kappa B quinase (IKK) em células C2C12 avaliando as atividades de HIF-
1α e miostatina. Resultados: A expressão protéica de HIF-1α foi significativamente alta
em células C2C12 sob tratamento com acetato de amônia comparado com controle. Uma
vez que ocorre o silenciamento de NF-kB, IKKα and IKKβ em células C2C12, não é observada
a expressão protéica de HIF-1α, sugerindo um cross-talking entre eles. A expressão
protéica de miostatina foi significativamente alta em células C2C12 silenciadas
para IKKα sob tratamento com acetato de amônia comparado com células C2C12 random
(controle), sugerindo que miostatina não é dependente da quinase IKKα. Conclusão:
Foi concluído que hiperamonemia é um ativador normóxico de HIF-1α através da
via de sinalização NF-kB resultando em sarcopenia via up-regulação de miostatina.
|
6 |
Conditionnement ischémique à distance : Rôles du facteur de transcription induit par l’hypoxie-1α et de l’apolipoprotéine A1 / Remote ischemic conditioning : roles of hypoxia-inducible factor-1α and apolipoprotein A1Kalakech, Hussein 26 November 2014 (has links)
La restauration rapide du flux sanguin est essentielle pour limiter l’étendue de l’infarctus myocardique mais elle est à l’origine de lésions irréversibles. Le préconditionnement ischémique à distance (RIPC) qui désigne l’application non invasive de brèves séquences d’ischémie/reperfusion au niveau d’un organe à distance du cœur peut prévenir la survenue de ces lésions de reperfusion. De nombreuses études suggèrent une implication de facteurs de transcription et de facteurs humoraux dans la cardioprotection induite par le RIPC, mais leurs identités restent inconnues. Dans la première partie du travail, nous avons donc étudié le rôle potentiel du facteur de transcription induit par l’hypoxie (HIF-1α) dans la phase précoce du RIPC. Nous avons ainsi démontré, en utilisant deux modèles expérimentaux : les souris transgéniques déficientes en HIF-1α et les rats traités par un inhibiteur pharmacologique de HIF-1α, que HIF-1α n’est pas indispensable pour cette phase du RIPC. Dans la deuxième partie de ce travail, nous avons essayé d’identifier, de façon directe cette fois, le ou les facteurs humoraux responsables de l’effet protecteur du RIPC. En se basant sur les résultats des études protéomiques démontrant une augmentation des concentrations plasmatiques d’apolipoprotéine A1 (Apo A1) suite au RIPC, nous avons alors cherché à mettre en évidence si cette protéine pourrait être un facteur circulant du RIPC. L’Apo A1, injectée directement avant la réalisation de l’infarctus chez le rat, était capable de reproduire l’effet cardioprotecteur et d’activer les mêmes voies de signalisation du RIPC. L’Apo A1 pourrait donc être un facteur humoral du RIPC. / Although early restoration of blood flow to the ischemic heart is essential to reduce the extent of myocardial infarction, reperfusion per se may cause irreversible tissue injury. Remote ischemic preconditioning (RIPC), the phenomenon whereby brief episodes of I/R are applied in distant tissues or organs, can protect the myocardium against reperfusion injuries. Several studies suggest that transcription factors and humoral mediators may be involved in RIPC mechanisms ; however the actual identity of these factors remains unknown. Therefore, in the first part of the study, we aimed to identify the role of hypoxia inducible factor (HIF-1α) in the acute phase of RIPC. We have thus demonstrated, using two animal models: partially HIF-1α-deficient mice and rats pretreated with a pharmacological inhibitor of HIF-1α, that HIF-1α is not crucial for this phase of RIPC. In the second part of the study, we have used a more direct approach and attempted to identify one or more humoral mediators of RIPC. Based on the results of proteomic studies showing an increase in plasmatic apolipoprotein A1 (Apo A1) levels following RIPC, we thus sought to determine if Apo A1 may constitute a blood-borne factor involved in RIPC’s protective effects. Our findings indicated that Apo A1 injected before myocardial infarction in rats acutely protected the heart, recapitulating RIPC-induced cardioprotection and that Apo A1 share some common signaling pathways with RIPC. Apo A1 may then be a humoral mediator of RIPC.
|
7 |
18F-FDG PET cannot predict expression of clinically relevant histopathological biomarkers in head and neck squamous cell carcinoma: a meta-analysisSurov, Alexey, Pech, Maciej, Eckert, Alexander, Arens, Christoph, Grosser, Oliver, Wienke, Andreas 02 May 2023 (has links)
BackgroundHead and neck squamous cell carcinoma (HNSCC) is a common cancer. Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) is a widely used imaging modality in HNSCC.PurposeTo provide evident data about associations between 18F-FDG PET and histopathology in HNSCC.Material and MethodsThe MEDLINE database was screened for associations between maximum standard uptake values (SUVmax) derived from 18F-FDG PET and histopathological features in HNSCC up to May 2020. Only papers containing correlation coefficients between SUVmax and histopathology were acquired. Overall, 23 publications were collected.ResultsThe following correlations were calculated: KI 67: 12 studies (345 patients), pooled correlation coefficient (PCC): 0.23 (95% confidence interval [CI] 0.06–0.40); hypoxia-inducible factor-1α: eight studies (240 patients), PCC: 0.24 (95% CI 0.06–0.42); microvessel density: three studies (64 patients), PCC: 0.33 (95% CI 0.02–0.65); vascular endothelial growth factor: two studies (59 cases), PCC: 0.27 (95% CI 0.02–0.51); tumor suppressor protein p53: four studies (159 patients), PCC: 0.05 (95% CI –0.41 to 0.51); epidermal growth factor receptor: two studies (124 patients), PCC: 0.21 (95% CI 0.05–0.37); tumor cell count: three studies (67 patients), PCC: 0.18 (95% CI –0.06 to 0.42); tumor cell apoptosis: two studies (40 patients), PCC: 0.07 (95% CI = –0.85 to 0.99); B-cell lymphoma-2 protein: two studies (118 patients); PCC: 0.04 (95% CI –0.65 to 0.74); glucose-transporter 1: 10 studies (317 patients), PCC: 0.20 (95% CI 0.10–0.30).ConclusionSUVmax derived from 18F-FDG PET cannot reflect relevant histopathological features in HNSCC.
|
8 |
Biomarkers in esophageal cancerTakala, H. (Heikki) 05 June 2012 (has links)
Abstract
Mediators of epithelial permeability, angiogenesis and invasion may serve as prognostic indicators and targets for therapies in esophageal cancer (EC). The expressions of claudins, hypoxia inducible factor-1α (HIF-1α), vascular endothelial growth factor-A (VEGF), nitric oxide synthases (iNOS, eNOS, nNOS) and toll-like receptor 9 (TLR9) were evaluated by immunohistochemistry in EC. The results were compared with clinicopathological variables, tumor proliferation and apoptosis.
All of the claudins were expressed in most of the cancers. Esophageal adenocarcinomas (EAC) displayed more often increased claudin 3 and 5 expression than esophageal squamous cell carcinomas (ESCC). Loss of claudin 3 expression associated with distant metastases in EC and a tendency in this direction was also observed for claudin 4. Cancers with stronger claudin 4 expression showed increased apoptosis in both EAC and ESCC.
HIF-1α was present in most of the ECs and like iNOS more often in ESCC than in EAC. Strong HIF-1α expression tended to associate with positive VEGF immunostaining. In ESCC, both strong HIF-1α expression and VEGF positivity tended to associate with increased microvessel density (MVD). In EAC, tumors showing VEGF positivity associated with increased MVD outside the tumor. Patients with strong HIF-1α expression had more often distant metastases than other patients in EC. There was no VEGF expression in normal esophageal mucosa and T3-4 tumors tended to be more often VEGF positive than T1-2 tumors.
The expression of TLR9 was more intensive in dysplasia than in normal epithelium and ESCC and abundant TLR9 expression could serve as a marker of squamous cell high grade dysplasia. Intensive TLR9 expression was associated with higher grade tumors and the presence of nodal and distant metastases in ESCC.
EC and its progression may be related to increased angiogenesis regulated by VEGF and HIF-1α. In EC, claudin expression varies along with the histology of the tumor. Claudin expression may be associated with apoptosis or proliferation and contribute to tumor behavior. An association was detected between moderate to strong expression of claudin 3 and a high TLR9 histoscore in ESCC. Altered expression of claudin 3 may result to upregulation of endosomal TLR9. TLR9 may serve as a marker for squamous cell dysplasia and ESCC progression. / Tiivistelmä
Solukerrosten läpäisevyyttä, verisuonten uudismuodostusta ja kasvainsolujen liikkuvuutta säätelevät tekijät voivat toimia ruokatorvisyövän ennustetekijöinä ja hoidon kohteina. Tässä tutkimuksessa selvitettiin klaudiinien, hypoksia-indusoituvan tekijän 1α (HIF-1α), verisuonen endoteelin kasvutekijän A (VEGF), kolmen typpioksidisyntaasin (iNOS, eNOS ja nNOS) sekä tollin kaltaisen reseptorin 9 (TLR9) ilmentymistä ja merkitystä ruokatorvisyövässä immunohistokemiallisin menetelmin. Tuloksia arvioitiin suhteessa proliferaatioon ja apoptoosiin.
Useimmat syöpäkasvaimet ilmensivät jokaista tutkittua klaudiinia. Ruokatorven rauhassyövässä ilmeni levyepiteelisyöpää useammin klaudiineja 3 ja 5. Klaudiinin 3 vähäinen ilmentyminen oli yhteydessä etäpesäkkeiseen tautiin. Sama suuntaus näkyi klaudiinin 4 kohdalla. Apoptoosia todettiin enemmän kasvaimissa, jotka ilmensivät muita enemmän klaudiini 4:ä.
Useimmat syöpäkasvaimet ilmensivät HIF-1α:a. Sekä iNOS että HIF-1α ilmentyivät runsaammin levyepiteeli- kuin rauhassyövässä. Tutkimus viittasi yhteyteen voimakkaan HIF-1α:n ilmentymisen ja VEGF:n ilmentymisen välillä. Voimakas HIF-1α:n ilmentyminen ja VEGF:n ilmentyminen vaikuttivat liittyvän ruokatorven levyepiteelisyövän uudissuonituksen lisääntymiseen. Rauhassyövän lisääntynyt uudissuonitus kasvaimen ulkopuolella saattaa liittyä VEGF:n ilmentymiseen. Potilailla, joiden kasvaimissa HIF-1α:n ilmentyminen oli voimakasta, todettiin etäpesäkkeitä muita useammin. VEGF:a ei todettu normaalissa limakalvossa, ja sen ilmentyminen vaikutti olevan yleisempää syvälle kasvavissa kuin pinnallisissa syövissä.
TLR9 ilmentyi voimakkaammin levyepiteelin dysplasiassa kuin normaalissa tai kasvainepiteelissä. Huonosti erilaistuvissa ja levinneissä kasvaimissa TLR9 ilmentyi voimakkaammin kuin muissa kasvaimissa.
Ruokatorvisyövän synty ja eteneminen voivat liittyä HIF:n ja VEGF:n säätelemään verisuonten uudismuodostukseen. Klaudiinit saattavat vaikuttaa syövän käyttäytymiseen myös apoptoosin ja proliferaation kautta. Tutkimuksessa todettiin yhteys lisääntyneen klaudiinin 3 ilmentymisen ja voimakkaasti ilmentyvän TLR9:n välillä. Muutos klaudiinin 3 ilmentymisessä saattaa lisätä levyepiteelin läpäisevyyttä johtaen TLR9:n aktivoitumiseen. TLR9 voi vaikuttaa ruokatorven levyepiteelin dysplasian ja syövän syntyyn sekä toimia vaikean dysplasian ja aggressiivisen levyepiteelisyövän merkkiaineena.
|
Page generated in 0.0968 seconds